PHI with Neurodermatitis (treatment- and symptom-free)
How does this condition affect your private health insurance?
Neurodermitis, or atopic dermatitis, is a chronic inflammatory skin condition marked by intense itching, dry skin, and recurrent eczematous lesions. While "behandlungs- u. beschwerdefrei" signifies periods of remission where symptoms are absent and no active treatment is needed, the underlying immunological predisposition persists. It is influenced by genetic and environmental factors, often appearing alongside asthma or allergic rhinitis. These symptom-free intervals are a primary goal of disease management, reflecting successful control rather than a complete cure. However, triggers can still provoke flare-ups, emphasizing the lifelong nature of the condition and the importance of ongoing skin care.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 15%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically several weeks to months, especially if untreated or severe, though symptoms can fluctuate significantly.
Duration of Illness (Lifetime)
Lifelong, characterized by periods of remission (treatment-free and symptom-free) interspersed with acute flare-ups.
Cost of Treatment (Initial)
Varies widely based on severity; can range from dozens to hundreds of Euros for initial consultations, emollients, and topical corticosteroids. More severe cases might incur higher costs for specialized treatments.
Cost of Treatment (Lifetime)
Significant over a lifetime, including ongoing emollients, episodic prescription medications (topical steroids, calcineurin inhibitors, biologics for severe cases), specialist visits, and potential alternative therapies. Costs can range from hundreds to thousands of Euros annually, depending on disease activity and severity.
Mortality Rate
Extremely low; typically not a direct cause of death, though severe secondary infections are rare risks.
Risk of Secondary Damages
Moderate to high. Physical damage includes skin thickening (lichenification), infections (bacterial, viral, fungal) due to impaired skin barrier and scratching. Psychological impacts like anxiety, depression, sleep disturbances, and social isolation are common, even during remission, due to the chronic nature and potential for recurrence.
Probability of Full Recovery
Variable. Approximately 50-70% of children experience remission by adolescence or adulthood, but a significant number continue to have symptoms or relapses. Complete, permanent recovery without any potential for recurrence is less common in adulthood.
Underlying Disease Risk
High. Often co-occurs with other atopic conditions such as asthma (20-40%), allergic rhinitis (30-50%), and food allergies (15-30%). Psychological comorbidities like anxiety and depression are also common.